5α-reductase and 11β-hydroxysteroid dehydrogenase activity in prepubertal hispanic girls with premature adrenarche

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4647-4651

  Silfen, Miriam E ^a   Shackleton, Cedric H L ^b   Manibo, Alexandra M ^b   Levine, Lenore S ^c   Sekhar, Deepa ^b   McMahon, Donald J ^c   Oberfield, Sharon E ^a,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTEROID; STEROID 5ALPHA REDUCTASE;

ADRENARCHE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PREPUBERTY; PRIORITY JOURNAL; RISK FACTOR; STEROID METABOLISM; URINE LEVEL;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADRENAL GLANDS; AGING; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CHOLESTENONE 5 ALPHA-REDUCTASE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HAIR; HISPANIC AMERICANS; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; HYPERANDROGENISM; OXIDOREDUCTASES; POLYCYSTIC OVARY SYNDROME; PUBERTY; PUBIC BONE;

EID: 0036776270     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-012045     Document Type: Article

References (30)

1. Ibañez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, Carrascosa A, Vicens-Calvet E 1993 Postpubertal outcome in girls diagnosed of premature pubarche during childhood: Increased frequency of functional ovarian hyperandrogenism. J Clin Endrocrinol Metab 76:1599-1603
2. Oppenheimer E, Linder B, DiMartino-Nardi J 1995 Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. J Clin Endocrinol Metab 80:614-618
3. Ibañez L, Potau N, Chacon P, Pascual C, Carrascosa A 1998 Hyperinsulinaemia, dyslipidaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 41:1057-1063
4. Ibañez L, Castell C, Tresserras R, Potau N 1999 Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche. Clin Endocrinol 51:395-401
5. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65:499-507
6. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
7. Ibañez L, Potau N, Francois I, DeZegher F 1998 Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83:3558-3562
8. DiMartino-Nardi J 1999 Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls. Acta Paediatr Suppl 433:67-72
9. Suikkari AM, Ruutianen K, Erkkola R, Seppala M 1989 Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum Reprod 4:136-139
10. Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC, Giudice LC 1999 Elevated serum levels of insulin-like growth factor I in polycystic ovary syndrome. J Clin Endocrinol Metab 84:3030-3035
11. Homburg R, Pariente C, Lunenfeld B, Jacobs HS 1992 The role of insulin-like growth factor-I and IGF binding protein-1 in the pathogenesis of polycystic ovary syndrome. Hum Reprod 7:1379-1383
12. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SS 1996 Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features. J Clin Endocrinol Metab 81:2854-2864
13. Ibañez L, Potau N, Zampolli M, Rique S, Saenger P, Carrascosa A 1997 Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 82:2283-2288
14. Vuguin P, Linder B, Rosenfeld FG, Saenger P, DiMartino-Nardi J 1999 The roles of insulin sensitivity, insulin-like growth factor I, and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. J Clin Endocrinol Metab 84:2037-2042
15. Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS, Oberfield SE 2002 Elevated free IGF-1 levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity. J Clin Endocrinol Metab 87:398-403
16. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC 1999 The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20:535-582
17. Kristiansen SB, Endoh A, Casson PR, Buster JE, Hornsby PJ 1997 Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids 62:258-265
18. Mesiano S, Katz SL, Lee JY, Jaffe RB 1997 Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: Implications for adrenal androgen regulation. J Clin Endocrinol Metab 82:1390-1396
19. L'Allemand D, Penhoat A, Lebrethon M-C, Ardevol R, Baehr V, Oelkers W, Saez JM 1996 Insulin-like growth factors enhance steroidogenic enzyme and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab 81:3892-3897
20. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62:904-910
21. Nestler JE, Jakubowicz DJ, Falcon de Vargas A, Brik C, Quintero N, Medina F 1998 Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83:2001-2005
22. Stewart PM, Shackleton CHL, Beastall GH, Edwards CRW 1990 5α-reductase activity in polycystic ovary syndrome. Lancet 335:431-433
23. Horton R, Pasupuletti V, Antonipillai I 1993 Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-1. Endocrinology 133:447-451
24. Rodin A, Thakkar H, Taylor NJ, Clayton R 1994 Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med 330:460-465
25. Chin D, Shackleton C, Prasad VK, Kohn B, David R, Imperato-McGinley J, Cohen H, McMahon DJ, Oberfield SE 2000 Increased 5α-reductase and normal 11β-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Ped Endocrinol Metab 13:253-259
26. Dotsch J, Rascher W 2002 The role of 11β-hydroxysteroid dehydrogenase activity in the metabolic syndrome: Lessons learned from the animal model. Eur J Endocrinol 146:603-605
27. Oberfield SE, Mayes DM, Levine LS 1990 Adrenal steroidogenic function in a Black and Hispanic population with precocious pubarche. J Clin Endocrinol Metab 70:76-82
28. 2) - A correction. Am J Clin Nutr 54:773-774
29. Palermo M, Gomez-Sanchez C, Roitman E, Shackleton CHL 1996 Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography/mass spectrometry with stable isotope-labeled internal standards. Steroids 61:583-589
30. Shackleton CHL 1993 Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45:127-140